Russoniello et al. examine the provisions, early impacts, successes, and challenges of Measure 110, a ballot initiative in Oregon that decriminalized possession of small quantities of all drugs and allocated vital funding to health services for people who use drugs.
Brandt provides insight on how the pharmacy profession can play a role in legal reform, regulatory policy creation, and pharmacy operations to broaden access to psychedelics while mitigating harm, using Canada as a case study.
C-EHRN outlines the importance of cooperation between
civil society organisations and state agencies, accompanied by adequate funding and a clear mandate for service providers in the face of a challenging and constantly changing harm reduction landscape.
CGHE and INHSU Prisons note that persons who are incarcerated experience the highest burdens of HCV globally and should therefore have the right to access HCV services, but they too often face systematic discrimination.
The EMCDDA present their findings of the largest European project to date in the emerging science of wastewater analysis, conducted in over 100 European cities and towns to explore the drug-taking habits of people who live in them.
WHRIN and ICW call for decriminalisation and the promotion of women's voices in decision-making forums, among many other recommendations, to address the challenges faced by women who live with HIV and use drugs.
IDPC sheds light on key political wins including in relation to countering racial discrimination in drug policy, recognising the importance of harm reduction for the right to health, protecting Indigenous rights, and promoting engagement by UN human rights bodies in drug policy debates.